Alliancebernstein L.P. Seagen Inc. Transaction History

Alliancebernstein L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $2.11 Million - $2.38 Million	11,015 Added 4.55%	252,867 $53.6 Million
Q2 2023 Aug 15, 2023	BUY	$187.64 - $206.25 $27.1 Million - $29.8 Million	144,450 Added 148.3%	241,852 $46.5 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $2.97 Million - $4.72 Million	23,254 Added 31.36%	97,402 $19.7 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $17,957 - $21,293	153 Added 0.21%	74,148 $9.53 Million
Q3 2022 Nov 15, 2022	SELL	$135.27 - $180.11 $4.33 Million - $5.77 Million	-32,027 Reduced 30.21%	73,995 $10.1 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $6.43 Million - $10.6 Million	-59,115 Reduced 35.8%	106,022 $18.8 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $3.3 Million - $4.35 Million	-27,574 Reduced 14.31%	165,137 $23.8 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $10 Million - $13.4 Million	70,387 Added 57.54%	192,711 $29.8 Million
Q3 2021 Nov 10, 2021	BUY	$142.45 - $169.82 $6.69 Million - $7.98 Million	46,976 Added 62.35%	122,324 $20.8 Million
Q2 2021 Jul 30, 2021	SELL	$135.08 - $161.1 $955,285 - $1.14 Million	-7,072 Reduced 8.58%	75,348 $11.9 Million
Q1 2021 May 06, 2021	BUY	$137.51 - $190.8 $990,347 - $1.37 Million	7,202 Added 9.57%	82,420 $11.4 Million
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $12.4 Million - $15.9 Million	75,218 New	75,218 $13.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.